Zobrazeno 1 - 10
of 496
pro vyhledávání: '"Hye-Jin Choi"'
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 5, Pp 1-11 (2018)
Allergic asthma: Drug to tackle allergy-triggered inflammation A drug that targets a key enzyme involved in airway tissue inflammation shows promise in the treatment of allergic asthma. The enzyme phospholipase D1 (PLD1) triggers airway inflammation
Externí odkaz:
https://doaj.org/article/6e422a1b0e704fa8a8ddef4c44781896
Autor:
Seung Tae Kim, Kee-Taek Jang, Jeeyun Lee, Heung-Moon Jang, Hye-Jin Choi, Hye-Lim Jang, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park
Publikováno v:
Translational Oncology, Vol 8, Iss 1, Pp 40-46 (2015)
BACKGROUND: We previously reported that the addition of erlotinib to gemcitabine and oxaliplatin (GEMOX) resulted in greater antitumor activity and might be a treatment option for patients with biliary tract cancers (BTCs). Molecular subgroup analysi
Externí odkaz:
https://doaj.org/article/6e68cdfd223a4dd3b92bede36ed829c6
Autor:
Hye Jin Choi, Asad Ullah, Mi Jin Jang, Ui Seok Lee, Min Chul Shin, Sang Hyun An, Dongseon Kim, Bo Hyun Kim, Gyu Man Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract For successful treatment of diseases, sufficient therapeutics must be provided to the body. Microneedle applications in therapeutic delivery and analytics sampling are restricted because of various issues, including smaller area for drug loa
Externí odkaz:
https://doaj.org/article/6d047752fdad444e979b96a6ab20a0f1
Autor:
Choong-kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, David Wai Meng Tai, Hyeyeong Kim, Krittiya Korphaisarn, Suebpong Tanasanvimon, San-Chi Chen, Ju Won Kim, Ilhwan Kim, Moonho Kim, Joan Choo, Sang-Bo Oh, Ching-Tso Chen, Woo Kyun Bae, Hongsik Kim, Seok Jae Huh, Chia-Jui Yen, Sejung Park, Dong Ki Lee, Landon Long Chan, Beodeul Kang, Minsu Kang, Raghav Sundar, Hye Jin Choi, Stephen Lam Chan, Hong Jae Chon, Myung-Ah Lee
Publikováno v:
Liver Cancer, Pp 1-15 (2024)
Introduction: Atezolizumab plus bevacizumab is a commonly used first-line regimen for advanced hepatocellular carcinoma (HCC) treatment owing to its superior outcomes compared to sorafenib. However, optimal subsequent treatment options for patients w
Externí odkaz:
https://doaj.org/article/48cd992dee674cbb8551afa29b350663
Publikováno v:
European Journal of Inflammation, Vol 13 (2015)
The purpose of this study was to identify the mechanism of lipopolysaccharide (LPS)-induced expression of tumor necrosis factor (TNF)-α in BEAS-2B. Toll-like receptor (TLR)4-specific siRNA was found to completely abolish the LPS-induced expression o
Externí odkaz:
https://doaj.org/article/b2f593cc33984a52833d8f48131b6a28
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102373 (2014)
Epidemiological evidence suggests that obesity is associated with inflammation of the respiratory tract and the pathogenesis of asthma. The purpose of this study was to examine the role of phospholipase D1 (PLD1) in leptin-induced expression of the p
Externí odkaz:
https://doaj.org/article/bdd9cea4877643de87c3830d5758e1c9
Autor:
Shukui Qin, Weijia Fang, Zhenggang Ren, Shuangyan Ou, Ho Yeong Lim, Feng Zhang, Kin Chung Lee, Hye Jin Choi, Jiandong Tong, Min Tao, Aibing Xu, Ashley Cheng, Chang-Hsien Lu, Chang-Fang Chiu, Mohamed Ibrahim Abdul Wahid, Shital Kamble, Josephine M. Norquist, Wenyan Zhong, Chen Li, Zhendong Chen
Publikováno v:
Liver Cancer (2024)
Introduction KEYNOTE-394 showed pembrolizumab significantly improved overall survival, progression-free survival, and objective response rate with manageable safety versus placebo for patients from Asia with previously treated advanced hepatocellular
Externí odkaz:
https://doaj.org/article/af000c83c7e94d4da9def0a30952f917
Autor:
Daye Mun, Minkyoung Kang, Minhye Shin, Hye Jin Choi, An Na Kang, Sangdon Ryu, Tatsuya Unno, Brighton E. Maburutse, Sangnam Oh, Younghoon Kim
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT Inflammatory bowel disease (IBD) is an inflammatory disease caused by the interaction of environmental and genetic factors, including diet and microbiota. Recent studies have suggested the effects of extracellular vesicles (EVs) on controlli
Externí odkaz:
https://doaj.org/article/1f52267274084319b673138b8925a2d4
Autor:
Si Won Lee, Jung Hye Kwon, Seung-hoon Beom, Sang Joon Shin, Hyo Song Kim, Sun Young Rha, Minkyu Jung, Joo Hyuk Sohn, Joong-Bae Ahn, Hyun Cheol Chung, Gun Min Kim, Hye Ryun Kim, Beodeul Kang, Youn Jung Hu, Hye Jin Choi
Publikováno v:
Palliative Medicine Reports, Vol 4, Iss 1, Pp 9-16 (2023)
Background: The acute palliative care unit (APCU) bridges between active cancer treatment and hospice care. However, no study has proven the efficacy of APCU in Korea. Objective: To evaluate the first-year outcomes of the patients admitted to an APCU
Externí odkaz:
https://doaj.org/article/6e04cc2ec19141fb935e1f00818277e8
Autor:
Hye Jin Choi, Young-Ah Kim, Junghwa Ryu, Kwan-Kyu Park, Sun-Jae Lee, Byung Seok Kim, Jeong-En Song, Joo Dong Kim
Publikováno v:
Molecules, Vol 29, Iss 3, p 593 (2024)
Liver damage caused by various factors results in fibrosis and inflammation, leading to cirrhosis and cancer. Fibrosis results in the accumulation of extracellular matrix components. The role of STAT proteins in mediating liver inflammation and fibro
Externí odkaz:
https://doaj.org/article/266c0b0d04ab4695a9cd66b24aca7501